These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3653181)

  • 21. Phase II trials of trimetrexate in advanced adult soft tissue sarcoma. Studies of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group.
    Eisenhauer EA; Wierzbicki R; Knowling M; Bramwell VH; Quirt IC
    Ann Oncol; 1991 Oct; 2(9):689-90. PubMed ID: 1835885
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II study of aclarubicin in previously untreated patients with advanced soft tissue sarcoma: a Southeastern Cancer Study Group trial.
    Bertrand M; Multhauf P; Bartolucci A; Ellison D; Gockerman J
    Cancer Treat Rep; 1985 Jun; 69(6):725-6. PubMed ID: 3860295
    [No Abstract]   [Full Text] [Related]  

  • 23. Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group.
    Steward WP; Verweij J; Somers R; Blackledge G; Clavel M; Van Oosterom AT; Greifenberg B; Soedirman J; Thomas D; Van Glabbeke M
    J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S193-7. PubMed ID: 1795008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study.
    Saiki JH; Baker LH; Stephens RL; Fabian CJ; Kraut EH; Fletcher WS
    Cancer Treat Rep; 1982 Aug; 66(8):1673-4. PubMed ID: 7105060
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
    Zidar BL; Baker LH; Rivkin SE; Balcerzak SP; Stephens RL
    Cancer Treat Rep; 1985 Sep; 69(9):1035-6. PubMed ID: 4028037
    [No Abstract]   [Full Text] [Related]  

  • 26. Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study.
    Saeter G; Alvegård TA; Monge OR; Strander H; Turesson I; Klepp R; Söderberg M; Wist E; Raabe N; Erlanson M; Solheim OP; Hannisdal E
    Eur J Cancer; 1997 Sep; 33(10):1551-8. PubMed ID: 9389914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral piritrexim--a phase II study in patients with advanced soft tissue sarcoma.
    Schiesel JD; Carabasi M; Magill G; Casper E; Cheng E; Marks L; Feyzi J; Clendeninn NJ; Smalley RV
    Invest New Drugs; 1992 Jul; 10(2):97-8. PubMed ID: 1500271
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.
    Chan C; Bartolucci A; Brenner D; Presant C; Davila E; Carpenter J; Greco FA; Clamon G; Moore J
    Cancer Treat Rep; 1986 Mar; 70(3):427-8. PubMed ID: 3456834
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effectiveness of carboplatin and etoposide selective intra-arterial chemotherapy for progressive soft-tissue sarcoma].
    Hamana T; Takahashi M; Miyagi N
    Gan To Kagaku Ryoho; 2000 May; 27(5):729-34. PubMed ID: 10832442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
    Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
    Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mitomycin C in the treatment of sarcomas of the soft tissues in the adult in an advanced phase].
    Di Lauro L; Balice A; Papaldo P; Lopez M
    Clin Ter; 1985 Oct; 115(2):83-5. PubMed ID: 3935361
    [No Abstract]   [Full Text] [Related]  

  • 32. Aclacinomycin A. Phase II evaluation in advanced soft tissue sarcoma.
    Pazdur R; Samson MK; Baker LH
    Am J Clin Oncol; 1987 Jun; 10(3):237-9. PubMed ID: 3473924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcoma.
    Bramwell VH; Brugarolas A; Mouridsen HT; Cheix F; De Jager F; van Oosterom AT; Vendrik CP; Pinedo HM; Sylvester R; De Pauw M
    Eur J Cancer (1965); 1979 Dec; 15(12):1511-3. PubMed ID: 575331
    [No Abstract]   [Full Text] [Related]  

  • 34. Chlorozotocin: phase II evaluation in patients with advanced sarcomas.
    Sordillo PP; Magill GB; Gralla RJ
    Cancer Treat Rep; 1981; 65(5-6):513-4. PubMed ID: 6453647
    [No Abstract]   [Full Text] [Related]  

  • 35. A phase I-II study of ifosfamide in combination with adriamycin in the treatment of adult soft tissue sarcoma.
    Mansi JL; Fisher C; Wiltshaw E; MacMillan S; King M; Stuart-Harris R
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1439-43. PubMed ID: 3181268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group.
    Judson I; Radford JA; Harris M; Blay JY; van Hoesel Q; le Cesne A; van Oosterom AT; Clemons MJ; Kamby C; Hermans C; Whittaker J; Donato di Paola E; Verweij J; Nielsen S
    Eur J Cancer; 2001 May; 37(7):870-7. PubMed ID: 11313175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection of large and objectively measurable target lesions in EORTC phase II trials: impact on recruitment and response rate. EORTC Soft Tissue and Bone Sarcoma Group (STBSG).
    Van Glabbeke M; van Oosterom AT; Steward W; Verweij J; Mouridsen H
    Eur J Cancer; 1993; 29A(14):1943-7. PubMed ID: 8280486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients.
    van Oosterom AT; Mouridsen HT; Nielsen OS; Dombernowsky P; Krzemieniecki K; Judson I; Svancarova L; Spooner D; Hermans C; Van Glabbeke M; Verweij J;
    Eur J Cancer; 2002 Dec; 38(18):2397-406. PubMed ID: 12460784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II trial of methylglyoxal-bis-guanylhydrazone (methyl-GAG) in patients with soft-tissue sarcomas.
    Sordillo PP; Magill GB; Welt S
    Am J Clin Oncol; 1985 Aug; 8(4):316-8. PubMed ID: 3909804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II evaluation of vindesine sulfate in patients with advanced sarcomas.
    Sordillo PP; Magill GB; Gralla RJ
    Cancer Treat Rep; 1981; 65(5-6):515-6. PubMed ID: 7237472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.